NOVITIUM PHARMA FDA Approval ANDA 216250

ANDA 216250

NOVITIUM PHARMA

FDA Drug Application

Application #216250

Application Sponsors

ANDA 216250NOVITIUM PHARMA

Marketing Status

Prescription001

Application Products

001SOLUTION;TOPICAL4%0LIDOCAINE HYDROCHLORIDELIDOCAINE HYDROCHLORIDE

FDA Submissions

UNKNOWN; ORIG1AP2022-03-23STANDARD

Submissions Property Types

ORIG1Null15

TE Codes

001PrescriptionAT

CDER Filings

NOVITIUM PHARMA
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 216250
            [companyName] => NOVITIUM PHARMA
            [docInserts] => ["",""]
            [products] => [{"drugName":"LIDOCAINE HYDROCHLORIDE","activeIngredients":"LIDOCAINE HYDROCHLORIDE","strength":"4%","dosageForm":"SOLUTION;TOPICAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"03\/23\/2022","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2022-03-23
        )

)

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.